Self-injectable obesity treatment Saxenda has been under fire constantly, because the obesity treatment has been abused as a weight management injection generating not only safety concerns but also questionable profit for the interest group.

Apparently, the government said it would provide answer to it in November. Some likely suggestions are individual unit packaging and separation of prescription and dispensing (SPD) system.

Undue profit generated from abusing Saxenda?

Demands for Saxenda has soared when the words got out that the injection is great option for controlling obesity. Accordingly, frequency of prescription and administration showed steep growth sin